通过虚拟查和生物评估识别BCKDK的假定全抑制剂
Chunqiong Li1, Quanjun Yang2, Li Zhang1
1Genomics Center, Chinese Institute for Brain Research, Beijing, China.
Journal of enzyme inhibition and medicinal chemistry
|December 7, 2023
概括
研究人员确定PPHN和POAB是针对分支链α-基酸脱酶激酶 (BCKDK) 的新型抑制剂. 这些化合物在治疗与分支链氨基酸 (BCAA) 积累相关的代谢疾病和癌症方面表现有前途.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 分链氨基酸 (BCAA) 的异常积累与代谢疾病和癌症有关.
- 分支链α-基托酸脱酶激酶 (BCKDK) 调节BCAA代谢,是治疗点.
研究的目的:
- 为了确定BCKDK的新型全抑制剂.
- 评估这些抑制剂在与BCAA失调相关的疾病中的治疗潜力.
主要方法:
- 集成的全结合部位预测和大型配体数据库的虚拟选.
- 进行生物活性评估测试,包括体内实验.
- 进行大量RNA测序 (RNA-seq) 分析以调查分子机制.
主要成果:
- 确定了PPHN和POAB作为具有高结合亲和度 (Kd值为3.9μM和1.86μM) 的新型假定全性BCKDK抑制剂.
- 在体内研究表明,在癌细胞中具有优异的激酶抑制活性,抗增殖和前性作用.
- RNA-seq分析显示,PPHN和POAB调节影响细胞生长的各种信号通路.
结论:
- PPHN和POAB是代谢疾病和癌症的强有力的治疗候选者.
- 这些抑制剂为管理与BCAA代谢功能障碍相关的疾病提供了有希望的策略.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
13:22Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
7.9K
相关概念视频
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Allosteric Regulation
58.0K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.0K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
